Summit Therapeutics partners with GSK for cancer drug combination trial
Go back to Summit Therapeutics partners with GSK for cancer drug combination trial| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 13.16 +0.73 (5.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.43 | 52 Week High | $19.75 | |||
| Open | $12.69 | 52 Week Low | $4.26 | |||
| Day High | $13.53 | P/E | N/A | |||
| Day Low | $12.57 | EPS | $0.00 | |||
| Volume | 7,073,744 | |||||
